Stockscreener 앱 받기
132.70
0.54%
0.71
시간 외 거래:
132.70
전일 마감가:
$131.99
열려 있는:
$133.04
하루 거래량:
1.11M
Relative Volume:
1.31
시가총액:
$7.48B
수익:
$738.26M
순이익/손실:
$48.89M
주가수익비율:
153.50
EPS:
0.8645
순현금흐름:
$91.69M
1주 성능:
+1.27%
1개월 성능:
+16.53%
6개월 성능:
-15.34%
1년 성능:
+0.81%
1일 변동 폭
$131.30
$141.46
1주일 범위
$125.83
$141.46
52주 변동 폭
$109.66
$175.77
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
132.70 | 7.44B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
451.29 | 165.37B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.69 | 45.13B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
47.51 | 39.17B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
77.82 | 39.14B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
221.22 | 32.94B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-17 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-01 | 개시 | HSBC Securities | Buy |
| 2025-09-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Goldman Sachs (GSCE) priced capped notes linked to Repligen (RGEN) stock - Stock Titan
[144] REPLIGEN CORP SEC Filing - Stock Titan
Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term Growth - Insider Monkey
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know - Yahoo Finance
Repligen Corp stock (US7607591002): Is its bioprocessing dominance strong enough to unlock new upsid - AD HOC NEWS
Repligen opens third training center in Netherlands facility - Investing.com
Repligen opens Netherlands hub for hands-on bioprocessing training - Stock Titan
Rothschild Redburn initiates Repligen stock with buy on bioprocessing strength - Investing.com Australia
Repligen Corp (RGEN) Shares Fall 3.7% -- What GF Score of 85 Tel - GuruFocus
Short Interest in Repligen Corporation (NASDAQ:RGEN) Rises By 28.0% - MarketBeat
Repligen Corp (RGEN) Stock Up 6.9% and Still Undervalued -- GF S - GuruFocus
Repligen Corp stock (US7607591002): Is bioprocessing demand strong enough to unlock new upside? - AD HOC NEWS
Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance
RGEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Analyst Lowers Price Target for RGEN Amid Continued Outperform R - GuruFocus
Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance Australia
Repligen (RGEN) Valuation Check After Mixed Share Price Returns And High P/E Multiple - Yahoo Finance
Repligen Corp (RGN.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (NASDAQ: RGEN) details 2025 growth, CEO pay and governance in 2026 proxy - stocktitan.net
Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Investors Anticipating Significant Movement in Repligen Shares? - Bitget
Are Options Traders Betting on a Big Move in Repligen Stock? - Zacks Investment Research
Will Repligen Corporation face regulatory challenges2026 Intraday Action & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart - capital.com
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Repligen Corp Stock: Bioprocessing Leader with Strong Growth in Biopharma Supply Chain - AD HOC NEWS
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.38% on Mar 27 - GuruFocus
Vanguard amends Schedule 13G/A for Repligen (RGEN): reports 0 shares - Stock Titan
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound? - finance.yahoo.com
RGEN PE Ratio & Valuation, Is RGEN Overvalued - Intellectia AI
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan
Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan
Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan
Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan
RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus
H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada
H.C. Wainwright raises Repligen stock price target on strong growth - Investing.com
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance
Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS
Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.86%
1.85%
자본화:
|
볼륨(24시간):